Browse by topic
Subscribe to our news

Case study: Leading pharma brand achieves 4.6x increased days on therapy

Overcoming an adherence challenge This case study shows how a leading pharmaceutical company used AI to optimize engagement in their patient support program. The program saw 15 additional days on therapy compared to non-AI targeting, as well as 5 times… Read

Solving polypharmacy non-adherence

Polypharmacy, the simultaneous use of multiple drugs, is becoming more common as the population ages. More than 30% of older adults in the United States take five or more drugs, typically for multiple chronic conditions. How polypharmacy contributes to non-adherence… Read

Improve adherence with patient psychology

Barriers to medication adherence can take the form of social determinants such as housing, employment and access to pharmacies – and systemic barriers such as pre-approvals, multiple prescriptions and affordability. But psychological barriers also play a major role. Understanding these… Read

Trending: COVID-19 accelerates healthcare tech

Chronic disease patients benefit from telehealth pilot With COVID-19 closing physicians’ offices and preventing patients from in-person appointments, healthcare organizations have substantially increased use of telehealth. One group of patients that has benefited from the COVID-19-driven rush to telehealth are… Read

How A.I. is optimizing medication synchronization

When patients have multiple prescriptions, especially for long-term conditions, refill dates often are not aligned and create barriers to adherence. So, pharmacies have been integrating medication synchronization programs into their workflow. Medication synchronization enables patients to fill all their prescriptions… Read

Overcoming barriers in physician partnerships

Pharmaceutical companies have aspired to make medication adherence programs more effective for years. A report from Credit Suisse shows that increased adherence could substantially increase revenue from 2020–2026 for leading pharma companies such as Merck, Pfizer, Bristol Myers Squibb, Johnson… Read

Case study: How a leading pharmacy improved both cost efficiency and effectiveness of patient interventions

Find out how a national retail pharmacy used artificial intelligence (AI) to generate a 2.3 times uplift in medication adherence. At the same time they improved targeting of dual patient interventions to make them more cost-effective. Making dual interventions for… Read

Establishing KPIs for your medication adherence program

Are you measuring what matters most for your brand? Many key performance indicators (KPIs) are used to measure the success of adherence programs, and they can vary across different pharmaceutical companies. According to Andrea Kasprzyk, Director of Sales at AllazoHealth,… Read

Trending: Payers increase focus on social determinants of health

Improved understanding about the effect of social determinants of health (SDOH) on population health outcomes have spurred increased innovation from payers. Social determinants of health are the conditions where patients live, learn, work and play. Key SDOH areas include employment,… Read

How pharma is advancing medication adherence

We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise comes from 24 years with… Read

Payer quality ratings: 7 best practices

Are you responsible for improving your plan’s quality ratings? Learn how to improve your performance on Star and other quality measures. Download our deck and get specific advice for payers on: The influence of population mix on performance Which patients… Read

Stay Connected

Subscribe to our emails for updates on trending topics, best practices, and advancements in healthcare and AI.